Dr. Shehla Wynne represents clients in intellectual property matters, with a particular focus on biopharmaceutical patent litigation in district courts and at the Patent Trial and Appeal Board (PTAB). She has experience with issues arising under the Hatch-Waxman Act and the Biologics Price Competition and Innovation Act (BPCIA). Her experience spans discovery, motion practice, trial, and appeals. Shehla also has experience in IP due diligence evaluations and competitive landscape analyses in the biotechnology and medical device sectors.
From 2019 to 2020, Shehla served as a law clerk to the Honorable Kathleen M. O'Malley of the United States Court of Appeals for the Federal Circuit. Prior to practicing law, Shehla earned her doctorate in biochemistry and molecular biology at Georgetown University, where her research centered on the molecular mechanisms of prostate cancer cell migration. She has coauthored several peer-reviewed articles in the field of cancer research. While in law school, Shehla was executive production editor from 2013 to 2014 of the AIPLA Quarterly Journal, a publication of the American Intellectual Property Law Association.
Shehla is a co-founder of Desi Writers' Lounge, a nonprofit organization committed to furthering literary awareness in South Asia.
Delaware District Dismisses BPCIA "Private Right" Claim; Says Controversy not Sufficiently Immediate
- The George Washington University (J.D. cum laude 2014); Georgetown University (Ph.D. in Biochemistry and Molecular & Cellular Biology 2011); University of the Punjab (B.S. in Biochemistry 2004; Director's Merit Award)
- Admitted in New York, U.S. Court of Appeals for the Federal Circuit, and U.S. District Courts for the Southern and Eastern Districts of New York; not admitted in District of Columbia; practice limited to cases in federal court
- Law Clerk to Judge Kathleen M. O'Malley, U.S. Court of Appeals, Federal Circuit (2019-2020) and extern to Judge O'Malley (2013-2014)
- Urdu, Hindi